Skip to content

Comparison of a low-carbohydrate diet and intermittent fasting in bariatric surgery patients

Comparison of the effects of a low-carbohydrate diet and intermittent fasting on anthropometric and body composition indices, lipid profile, and food cravings in individuals eligible for bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250816066880N1
Enrollment
84
Registered
2025-09-14
Start date
2025-10-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients eligible for bariatric surgery. Bariatric surgery status

Interventions

Intervention 1: Intervention group one: Our intervention includes prescribing a diet with a low-carbohydrate, low-calorie diet. This diet is explained to the patient at the beginning of the study and

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 65 years People eligible for bariatric surgery with a body mass index (BMI) of 35 kg/m2 or greater with obesity-related complications, or a BMI of 40 kg/m2 or greater without complications

Exclusion criteria

Exclusion criteria: Severe mental disorders according to medical records History of bariatric surgery Taking insulin as part of diabetes treatment Following a vegetarian diet History of surgery in the past 6 months Alcohol consumption Having certain medical conditions, including acute or chronic kidney failure, liver failure, cancer, acid-base disorders, and active peptic ulcers

Design outcomes

Primary

MeasureTime frame
Body mass index. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Dividing weight in kilograms with a seca digital scale by height in square meters with a seca stadiometer.;Waist circumference. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Tape measure.;Hip circumference. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Tape measure.

Secondary

MeasureTime frame
Food craving score. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Food Craving Questionnaire-Trait (FCQ-T).;Appetite score. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Simplified Appetite Nutritional Questionnaire (SNAQ).;Body fat percentage. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Tanita BC418 Body Analysis Device.;Fat free mass. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Tanita BC418 Body Analysis Device.;Body water. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Tanita BC418 Body Analysis Device.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Triglyceride test with enzymatic colorimetric method.;High Density Lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: High density lipoprotein test with homogeneous direct enzymatic assay.;High Density Lipoprotein. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: calculating using Friedwald formula.;Total cholesterol. Timepoint: At the beginning of the study (before the intervention) and 28 days after the dietary intervention. Method of measurement: Total cholesterol test with enzymatic colorimetric method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactToktam Khosravi

Yazd University of Medical Sciences

toktam.akhosravi@gmail.com+98 56 3240 4674

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026